In order to patent a new chemical compound, which is to be used for medical purposes, it is necessary to present already in the patent application the results of a research confirming its therapeutic effects.

In the latest issue of the magazine “The World of Pharmaceutical Industry” (“Świat Przemysłu Farmaceutycznego”) Barbara Milczarek, a patent attorney at Patpol, discussed the obligation of a sufficient disclosure of invention in the context of the application procedures.

We invite you to read the full article in polish.

Patpol has been awarded the title “Symbol of Effective Management 2021”!

We are happy to announce that Patpol has been awarded the title "Symbol of Effective Czytaj dalej

Trading on a good name

Among all the trademarks commonly used, one can select a group of marks that are Czytaj dalej

Registration of trademarks in 3D virtual network worlds – metaverse? Why not!

Monika Zielińska, attorney at law and patent attorney, in the video for news agency Newseria Czytaj dalej